SG158841A1 - Genes - Google Patents

Genes

Info

Publication number
SG158841A1
SG158841A1 SG200908691-9A SG2009086919A SG158841A1 SG 158841 A1 SG158841 A1 SG 158841A1 SG 2009086919 A SG2009086919 A SG 2009086919A SG 158841 A1 SG158841 A1 SG 158841A1
Authority
SG
Singapore
Prior art keywords
seq
sequence shown
sequence
genes
pdcd6
Prior art date
Application number
SG200908691-9A
Other languages
English (en)
Inventor
Chee Furng Wong
Miranda Gek Sim Yap
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG158841A1 publication Critical patent/SG158841A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SG200908691-9A 2004-12-30 2005-12-28 Genes SG158841A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64033304P 2004-12-30 2004-12-30

Publications (1)

Publication Number Publication Date
SG158841A1 true SG158841A1 (en) 2010-02-26

Family

ID=36615341

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200908691-9A SG158841A1 (en) 2004-12-30 2005-12-28 Genes

Country Status (9)

Country Link
US (5) US7846894B2 (de)
EP (6) EP2298887A1 (de)
JP (1) JP5089400B2 (de)
KR (1) KR20070082597A (de)
CN (3) CN101133156A (de)
AU (1) AU2005322686B2 (de)
IL (1) IL183361A0 (de)
SG (1) SG158841A1 (de)
WO (1) WO2006071200A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3626254A1 (de) 2012-03-16 2020-03-25 University Health Network Lösliches toso protein und dessen verwendung zur behandlung von autoimmunerkrankungen
EP2674495A1 (de) * 2012-06-14 2013-12-18 Sanofi CHO-Expressionssystem
WO2014068048A1 (en) * 2012-11-05 2014-05-08 Celonic Ag Expression system
EP3016982A4 (de) 2013-07-03 2017-02-22 University Health Network Anti-toso-antikörper
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN107630038A (zh) * 2017-09-15 2018-01-26 浙江大学 提高老年大鼠骨髓间充质干细胞移植后生存能力的方法
WO2019180607A1 (en) * 2018-03-19 2019-09-26 Centre For Cellular And Molecular Platforms A vector, a host cell and a method thereof
CN108359632A (zh) * 2018-03-30 2018-08-03 吉林冠界生物技术有限公司 Mdck细胞系、复制病毒的方法及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPH02500329A (ja) 1987-05-21 1990-02-08 クリエイテイブ・バイオマリキユールズ・インコーポレーテツド ターゲット化多機能蛋白質
EP0436597B1 (de) 1988-09-02 1997-04-02 Protein Engineering Corporation Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
ES2052027T5 (es) 1988-11-11 2005-04-16 Medical Research Council Clonacion de secuencias de dominio variable de inmunoglobulina.
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6747138B1 (en) 1995-04-03 2004-06-08 Regents Of The University Of Michigan Methods and compositions for regulating Fas-associated apoptosis
EP0816497A3 (de) * 1996-06-26 1999-12-22 Smithkline Beecham Corporation Menschliche Requiempolypeptide für Apoptosis
US6544523B1 (en) 1996-11-13 2003-04-08 Chiron Corporation Mutant forms of Fas ligand and uses thereof
GB9625283D0 (en) * 1996-12-04 1997-01-22 Janssen Pharmaceutica Nv Vertebrate homologues of unc-53 protein of c.elegans or functional eqivalents thereof and cdna sequences coding for said homologue
US20040143111A1 (en) * 1997-04-17 2004-07-22 Incyte Corporation Novel apoptosis-associated protein
US6451759B1 (en) 1998-01-14 2002-09-17 The Regents Of The University Of California Noncleavable Fas ligand
AU3753099A (en) * 1998-04-21 1999-11-08 Trustees Of Boston University Novel genes and methods that modulate apoptosis
US6683168B1 (en) 1998-04-21 2004-01-27 Boston Medical Center Corporation Genes and methods that modulate apoptosis
US6015712A (en) * 1999-07-19 2000-01-18 Isis Pharmaceuticals Inc. Antisense modulation of FADD expression
WO2001023592A2 (en) 1999-09-27 2001-04-05 Genentech, Inc. Methods for making recombinant proteins using apoptosis inhibitors
US7575860B2 (en) * 2000-03-07 2009-08-18 Evans David H DNA joining method
US20040023385A1 (en) * 2002-08-05 2004-02-05 Isis Pharmaceuticals Inc. Antisense modulation of requiem expression
US7326768B2 (en) * 2003-02-05 2008-02-05 Juan Saus Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
CN1548054A (zh) * 2003-05-08 2004-11-24 陆爱丽 预防或治疗sars冠状病毒的药物

Also Published As

Publication number Publication date
JP5089400B2 (ja) 2012-12-05
CN101875692A (zh) 2010-11-03
CN101875957A (zh) 2010-11-03
US20080295190A1 (en) 2008-11-27
EP1831366A2 (de) 2007-09-12
WO2006071200A3 (en) 2007-01-25
WO2006071200A2 (en) 2006-07-06
KR20070082597A (ko) 2007-08-21
CN101133156A (zh) 2008-02-27
AU2005322686B2 (en) 2012-01-19
US20110318316A1 (en) 2011-12-29
IL183361A0 (en) 2007-09-20
AU2005322686A1 (en) 2006-07-06
US7846894B2 (en) 2010-12-07
EP2298888A1 (de) 2011-03-23
EP2298887A1 (de) 2011-03-23
US20110318317A1 (en) 2011-12-29
EP1997890A1 (de) 2008-12-03
EP2298889A1 (de) 2011-03-23
JP2008526200A (ja) 2008-07-24
US20110129927A1 (en) 2011-06-02
EP2298890A1 (de) 2011-03-23
US20110318831A1 (en) 2011-12-29

Similar Documents

Publication Publication Date Title
SG158841A1 (en) Genes
WO2007035600A3 (en) Natriuretic activities
HK1054619A1 (en) Fuel cartridge and reaction chamber.
HK1156860A1 (en) Compstatin analogs with improved activity compstatin
PL2332968T3 (pl) Stabilizowane alfa-helikalne peptydy i ich zastosowania
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
WO2005007818A3 (en) Exo-specific amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof
AU2003248119A1 (en) Novel peptide synthase gene
EP1733039A4 (de) Verbesserte bakterienwirtszelle zur direkten expression von peptiden
TW200722436A (en) A peptide-immunoglobulin-conjugate
WO2006046239A3 (en) A thymus-specific protein
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO2003074546A8 (de) Streptavidin-bindungspeptid
ATE333520T1 (de) Neuartige polynukleotide und polypeptide des ifnalpha-21 gens
WO2006127822A3 (en) Scytovirin domain 1 related polypeptides
WO2005049806A3 (en) Novel nucleic acids and polypeptides
WO2003093305A3 (en) Teneurin c-terminal associated peptides (tcap) and uses thereof
MX2009009370A (es) Conjugados del complemento de peptido.
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
WO2003091383A3 (fr) Epitopes t de l'antigene epha2.
AU2003238955A1 (en) Aquariums switching current water director (scwd)
AU2003282465A8 (en) Isolated mammalian membrane protein genes
WO2005077975A3 (en) Polypeptides comprising the pleckstrin homology domain of ect2 and their binding specificities to phosphatidylinositols
EP2129359A4 (de) Chimärer peptidantagonist für gpcr135 oder gpcr142
HK1082510A1 (en) Promoter to il-18bp, its preparation and use